Free Newsletter
FDA: Mylan plant probe to continue
The FDA's investigation of Mylan's quality-control practices at a Morgantown, WV plant will continue for a "few weeks," an agency spokesman told the Dominion Post. The statement comes after Mylan chief Robert Coury backpedaled on his previous claims that FDA had wrapped up the probe. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: